107 related articles for article (PubMed ID: 31385395)
1. Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome.
Kubota Y; Uryu K; Ito T; Seki M; Kawai T; Isobe T; Kumagai T; Toki T; Yoshida K; Suzuki H; Kataoka K; Shiraishi Y; Chiba K; Tanaka H; Ohki K; Kiyokawa N; Kagawa J; Miyano S; Oka A; Hayashi Y; Ogawa S; Terui K; Sato A; Hata K; Ito E; Takita J
Cancer Sci; 2019 Oct; 110(10):3358-3367. PubMed ID: 31385395
[TBL] [Abstract][Full Text] [Related]
2. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
Brown AL; de Smith AJ; Gant VU; Yang W; Scheurer ME; Walsh KM; Chernus JM; Kallsen NA; Peyton SA; Davies GE; Ehli EA; Winick N; Heerema NA; Carroll AJ; Borowitz MJ; Wood BL; Carroll WL; Raetz EA; Feingold E; Devidas M; Barcellos LF; Hansen HM; Morimoto L; Kang AY; Smirnov I; Healy J; Laverdière C; Sinnett D; Taub JW; Birch JM; Thompson P; Spector LG; Pombo-de-Oliveira MS; DeWan AT; Mullighan CG; Hunger SP; Pui CH; Loh ML; Zwick ME; Metayer C; Ma X; Mueller BA; Sherman SL; Wiemels JL; Relling MV; Yang JJ; Lupo PJ; Rabin KR
Blood; 2019 Oct; 134(15):1227-1237. PubMed ID: 31350265
[TBL] [Abstract][Full Text] [Related]
3. Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndrome.
de Smith AJ; Walsh KM; Morimoto LM; Francis SS; Hansen HM; Jeon S; Gonseth S; Chen M; Sun H; Luna-Fineman S; Antillón F; Girón V; Kang AY; Smirnov I; Shao X; Whitehead TP; Barcellos LF; Jolly KW; Healy J; Laverdière C; Sinnett D; Taub JW; Birch JM; Thompson PD; Pombo-de-Oliveira MS; Spector LG; DeWan AT; Mueller BA; Chiang C; Metayer C; Ma X; Wiemels JL
Leukemia; 2019 Nov; 33(11):2746-2751. PubMed ID: 31296947
[No Abstract] [Full Text] [Related]
4. Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia.
Li Z; Chang TC; Junco JJ; Devidas M; Li Y; Yang W; Huang X; Hedges DJ; Cheng Z; Shago M; Carroll AJ; Heerema NA; Gastier-Foster J; Wood BL; Borowitz MJ; Sanclemente L; Raetz EA; Hunger SP; Feingold E; Rosser TC; Sherman SL; Loh ML; Mullighan CG; Yu J; Wu G; Lupo PJ; Rabin KR; Yang JJ
Blood; 2023 Jul; 142(2):172-184. PubMed ID: 37001051
[TBL] [Abstract][Full Text] [Related]
5. Down syndrome and leukemia: from basic mechanisms to clinical advances.
Baruchel A; Bourquin JP; Crispino J; Cuartero S; Hasle H; Hitzler J; Klusmann JH; Izraeli S; Lane AA; Malinge S; Rabin KR; Roberts I; Ryeom S; Tasian SK; Wagenblast E
Haematologica; 2023 Oct; 108(10):2570-2581. PubMed ID: 37439336
[TBL] [Abstract][Full Text] [Related]
6. Converging genetic and epigenetic drivers of paediatric acute lymphoblastic leukaemia identified by an information-theoretic analysis.
Koldobskiy MA; Jenkinson G; Abante J; Rodriguez DiBlasi VA; Zhou W; Pujadas E; Idrizi A; Tryggvadottir R; Callahan C; Bonifant CL; Rabin KR; Brown PA; Ji H; Goutsias J; Feinberg AP
Nat Biomed Eng; 2021 Apr; 5(4):360-376. PubMed ID: 33859388
[TBL] [Abstract][Full Text] [Related]
7. Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome.
Laurent AP; Kotecha RS; Malinge S
Leukemia; 2020 Aug; 34(8):1984-1999. PubMed ID: 32433508
[TBL] [Abstract][Full Text] [Related]
8. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
Gao Q; Ryan SL; Iacobucci I; Ghate PS; Cranston RE; Schwab C; Elsayed AH; Shi L; Pounds S; Lei S; Baviskar P; Pei D; Cheng C; Bashton M; Sinclair P; Bentley DR; Ross MT; Kingsbury Z; James T; Roberts KG; Devidas M; Fan Y; Chen W; Chang TC; Wu G; Carroll A; Heerema N; Valentine V; Valentine M; Yang W; Yang JJ; Moorman AV; Harrison CJ; Mullighan CG
Blood; 2023 Aug; 142(8):711-723. PubMed ID: 37216686
[TBL] [Abstract][Full Text] [Related]
9. Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases.
Peroni E; Gottardi M; D'Antona L; Randi ML; Rosato A; Coltro G
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895004
[TBL] [Abstract][Full Text] [Related]
10. Widespread domain-like perturbations of DNA methylation in whole blood of Down syndrome neonates.
Henneman P; Bouman A; Mul A; Knegt L; van der Kevie-Kersemaekers AM; Zwaveling-Soonawala N; Meijers-Heijboer HEJ; van Trotsenburg ASP; Mannens MM
PLoS One; 2018; 13(3):e0194938. PubMed ID: 29601581
[TBL] [Abstract][Full Text] [Related]
11. Epigenome-wide association study of acute lymphoblastic leukemia in children with Down syndrome.
Li S; Sok P; Xu K; Muskens IS; Elliott N; Myint SS; Pandey P; Hansen HM; Morimoto LM; Kang AY; Metayer C; Ma X; Mueller BA; Roy A; Roberts I; Rabin KR; Brown AL; Lupo PJ; Wiemels JL; de Smith AJ
Blood Adv; 2022 Jul; 6(14):4132-4136. PubMed ID: 35588500
[No Abstract] [Full Text] [Related]
12. Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia.
Ryba T; Battaglia D; Chang BH; Shirley JW; Buckley Q; Pope BD; Devidas M; Druker BJ; Gilbert DM
Genome Res; 2012 Oct; 22(10):1833-44. PubMed ID: 22628462
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics of acute lymphocytic leukemia.
Garcia-Manero G; Yang H; Kuang SQ; O'Brien S; Thomas D; Kantarjian H
Semin Hematol; 2009 Jan; 46(1):24-32. PubMed ID: 19100365
[TBL] [Abstract][Full Text] [Related]
14. Beyond chromosome analysis: Additional genetic testing practice in a Down syndrome clinic.
Harisinghani A; Raffaele G; Zawatsky CB; Santoro SL
Am J Med Genet C Semin Med Genet; 2023 Dec; 193(4):e32063. PubMed ID: 37774106
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic analysis of stem cells from chorionic villi uncovers the impact of chromosomes 2, 6 and 22 in the clinical manifestations of Down syndrome.
Vaiasicca S; Melone G; James DW; Quintela M; Preziuso A; Finnell RH; Conlan RS; Francis LW; Corradetti B
Stem Cell Res Ther; 2023 Sep; 14(1):265. PubMed ID: 37740230
[TBL] [Abstract][Full Text] [Related]
16. All about Down syndrome ALL.
Gu Z; Izraeli S
Blood; 2023 Jul; 142(2):126-128. PubMed ID: 37440267
[No Abstract] [Full Text] [Related]
17. SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome.
Moisoiu V; Sas V; Stefancu A; Iancu SD; Jurj A; Pasca S; Iluta S; Zimta AA; Tigu AB; Teodorescu P; Turcas C; Blag C; Dima D; Popa G; Arghirescu S; Man S; Colita A; Leopold N; Tomuleasa C
Front Bioeng Biotechnol; 2021; 9():703268. PubMed ID: 34368097
[TBL] [Abstract][Full Text] [Related]
18. Gene Expression Studies in Down Syndrome: What Do They Tell Us about Disease Phenotypes?
Chapman LR; Ramnarine IVP; Zemke D; Majid A; Bell SM
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474215
[TBL] [Abstract][Full Text] [Related]
19. It is more "unbalanced" than you think.
Malinge S
Blood; 2023 Mar; 141(10):1095-1096. PubMed ID: 36893009
[No Abstract] [Full Text] [Related]
20. Acute lymphoblastic leukemia and down syndrome: 6-mercaptopurine and methotrexate metabolites during maintenance therapy.
Østergaard A; Bohnstedt C; Grell K; Degn M; Zeller B; Taskinen M; Hafsteinsdottir S; Björgvinsdóttir H; Heyman M; Hoogerbrugge P; Schmiegelow K;
Leukemia; 2021 Mar; 35(3):863-866. PubMed ID: 32623444
[No Abstract] [Full Text] [Related]
[Next] [New Search]
